Key facts
- Morrow’s last known valuation is $28.1M (Jul 2025).
- It has raised $37.6M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Participatiemaatschappij Vlaanderen, New Science Ventures, Fidimec, Ghent University, Imec — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Morrow
- ·The full record, as it builds
Funding rounds
No funding rounds for Morrow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Morrow
Manufacturer of progressive glasses and eyewear intended to offer automatically focusing eyeglasses. The company's technology consists of two precise, thin-cut optical lenses embedded with active liquid crystal that allows a user to switch up their vision from near to far in just a few seconds with the help of a small surge of electrical current, enabling users to experience a sharper focus and a much wider view.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Ghent, Belgium
- Founded
- 2016
- Employees
- 18
- Website
- morroweyewear.com/
- Ownership
- Privately Held (backing)
Morrow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Morrow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Morrow in its N-PORT filings yet. We sweep new filings monthly.